Percy H. Carter, CHIEF SCIENTIFIC OFFICER at Blueprint Medicines Corp (BPMC), sold 4,872 shares at $106.43 ($519K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Seasonal sale ($519k) by CHIEF SCIENTIFIC OFFICER — this insider has traded BPMC in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.43 | 2,436 | $259K | 50.0% |
| 2 | $106.43 | 2,436 | $259K | 50.0% |
| Total | $106.43 avg | 4,872 | $519K | 100% |
| Filing → |
| BPMC | SELL | 2025-03-07 | $313K | — | Filing → |
| BPMC | SELL | 2024-06-07 | $421K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $415K | — | Filing → |